February 15-16, 2022
← Back to Page
Council Contact Information
Please use the following email address to contact the Council: [email protected]
Agenda
CLOSED SESSION1 – February 15, 2022 – 11:00 a.m. EST | |||
---|---|---|---|
Scheduled | Event | Speaker | Supporting Documents |
OPEN SESSION – February 15, 2022 – noon EST | |||
OPEN SESSION – February 16, 2022 – 11:00 a.m. EST | |||
11:00 a.m. | I. Review of Confidentiality and Conflict of Interest | Dr. Pat Mastin | |
II. Consideration of Grant Applications | Dr. Pat Mastin and DERT staff | ||
11:45 a.m. | Adjourn Closed Session | ||
BREAK | |||
noon | III. Call to Order and Opening Remarks | Dr. Rick Woychik | |
IV. Review of Confidentiality and Conflict of Interest | Dr. Pat Mastin | ||
V. Consideration of September and November 2021 Meeting Minutes | Dr. Pat Mastin |
| |
12:15 p.m. | VI. Report of the Director, NIEHS | Dr. Rick Woychik | |
1:15 p.m. | VII. Next Generation Innovation in Toxicology at NIEHS | Dr. Brian Berridge | |
2:00 p.m. | BREAK | ||
2:15 p.m. | VIII. NIBIB and the Pandemic Response: New Opportunities for Accelerating Innovation from in Vitro Diagnostics (IVD) to Medical Imaging | Dr. Bruce Tromberg | |
3:15 p.m. | IX. SMCHD1 and Epigenetics: Lessons Learned From Patients Born Without a Nose | Dr. Natalie Shaw | |
4:00 p.m. | X. Environmental Health Perspectives | Dr. Joel Kaufman | |
4:30 p.m. | ADJOURN | ||
11:00 a.m. | XI. DERT Report ... Including Summary of FY2021 Expenditures | Dr. Pat Mastin and staff |
|
noon | XII. Oceans and Human Health Concept | Dr. Anika Dzierlenga | |
12:45 p.m. | XII. CCRP Initiative: Chemical Threat Agent Inhalational Exposure Research Resource Concept | Dr. Sri Nadadur | |
1:15 p.m. | BREAK | ||
1:30 p.m. | XIV. Children Centers Update | Dr. Kim Gray | |
2:30 p.m. | XV. Reporting Back Environmental Health Research Results | Council Discussion | |
4:00 p.m. | XVI. Working Group Update | Dr. Karen Vasquez | |
5:00 p.m. | ADJOURN |
1 This portion of the meeting is being closed to the public in accordance with the provisions set forth in Section 552b(c)(4) and 552b(c)(6), Title 5, U.S. Code and Section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2).